These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12379360)

  • 1. Structural diversity of antibody catalysts.
    Golinelli-Pimpaneau B
    J Immunol Methods; 2002 Nov; 269(1-2):157-71. PubMed ID: 12379360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of the complex of a catalytic antibody Fab fragment with a transition state analog: structural similarities in esterase-like catalytic antibodies.
    Charbonnier JB; Carpenter E; Gigant B; Golinelli-Pimpaneau B; Eshhar Z; Green BS; Knossow M
    Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11721-5. PubMed ID: 8524836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diverse structural solutions to catalysis in a family of antibodies.
    Gigant B; Tsumuraya T; Fujii I; Knossow M
    Structure; 1999 Nov; 7(11):1385-93. PubMed ID: 10574796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-resolution crystal structure of the Fab-fragments of a family of mouse catalytic antibodies with esterase activity.
    Ruzheinikov SN; Muranova TA; Sedelnikova SE; Partridge LJ; Blackburn GM; Murray IA; Kakinuma H; Takahashi-Ando N; Shimazaki K; Sun J; Nishi Y; Rice DW
    J Mol Biol; 2003 Sep; 332(2):423-35. PubMed ID: 12948492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural insights into the evolution of an antibody combining site.
    Wedemayer GJ; Patten PA; Wang LH; Schultz PG; Stevens RC
    Science; 1997 Jun; 276(5319):1665-9. PubMed ID: 9180069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of hapten binding and catalytic determinants in a family of catalytic antibodies.
    Ulrich HD; Schultz PG
    J Mol Biol; 1998 Jan; 275(1):95-111. PubMed ID: 9451442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel reactions catalysed by antibodies.
    Golinelli-Pimpaneau B
    Curr Opin Struct Biol; 2000 Dec; 10(6):697-708. PubMed ID: 11114507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thermodynamic and structural basis for transition-state stabilization in antibody-catalyzed hydrolysis.
    Oda M; Ito N; Tsumuraya T; Suzuki K; Sakakura M; Fujii I
    J Mol Biol; 2007 May; 369(1):198-209. PubMed ID: 17428500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crossreactivity, efficiency and catalytic specificity of an esterase-like antibody.
    Gigant B; Charbonnier JB; Eshhar Z; Green BS; Knossow M
    J Mol Biol; 1998 Dec; 284(3):741-50. PubMed ID: 9826512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative analysis of the immunological evolution of antibody 28B4.
    Yin J; Mundorff EC; Yang PL; Wendt KU; Hanway D; Stevens RC; Schultz PG
    Biochemistry; 2001 Sep; 40(36):10764-73. PubMed ID: 11535051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for 'lock and key' character in an anti-phosphonate hydrolytic antibody catalytic site augmented by non-reaction centre recognition: variation in substrate selectivity between an anti-phosphonate antibody, an anti-phosphate antibody and two hydrolytic enzymes.
    Sonkaria S; Boucher G; Flórez-Olvarez J; Said B; Hussain S; Ostler EL; Gul S; Thomas EW; Resmini M; Gallacher G; Brocklehurst K
    Biochem J; 2004 Jul; 381(Pt 1):125-30. PubMed ID: 15053743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Routes to catalysis: structure of a catalytic antibody and comparison with its natural counterpart.
    Haynes MR; Stura EA; Hilvert D; Wilson IA
    Science; 1994 Feb; 263(5147):646-52. PubMed ID: 8303271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The structural and functional basis of antibody catalysis.
    Wade H; Scanlan TS
    Annu Rev Biophys Biomol Struct; 1997; 26():461-93. PubMed ID: 9241427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substrate-assisted antibody catalysis.
    Deng S; Bharat N; de Prada P; Landry DW
    Org Biomol Chem; 2004 Feb; 2(3):288-90. PubMed ID: 14747854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural evidence for a programmed general base in the active site of a catalytic antibody.
    Golinelli-Pimpaneau B; Goncalves O; Dintinger T; Blanchard D; Knossow M; Tellier C
    Proc Natl Acad Sci U S A; 2000 Aug; 97(18):9892-5. PubMed ID: 10963661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of shape complementarity and catalytic efficiency from a primordial antibody template.
    Xu J; Deng Q; Chen J; Houk KN; Bartek J; Hilvert D; Wilson IA
    Science; 1999 Dec; 286(5448):2345-8. PubMed ID: 10600746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural convergence in the active sites of a family of catalytic antibodies.
    Charbonnier JB; Golinelli-Pimpaneau B; Gigant B; Tawfik DS; Chap R; Schindler DG; Kim SH; Green BS; Eshhar Z; Knossow M
    Science; 1997 Feb; 275(5303):1140-2. PubMed ID: 9027317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis for amide hydrolysis catalyzed by the 43C9 antibody.
    Thayer MM; Olender EH; Arvai AS; Koike CK; Canestrelli IL; Stewart JD; Benkovic SJ; Getzoff ED; Roberts VA
    J Mol Biol; 1999 Aug; 291(2):329-45. PubMed ID: 10438624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune recognition, antigen design, and catalytic antibody production.
    Tramontano A
    Appl Biochem Biotechnol; 1994; 47(2-3):257-73; discussion 273-5. PubMed ID: 7944342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A structural basis for transition-state stabilization in antibody-catalyzed hydrolysis: crystal structures of an abzyme at 1. 8 A resolution.
    Kristensen O; Vassylyev DG; Tanaka F; Morikawa K; Fujii I
    J Mol Biol; 1998 Aug; 281(3):501-11. PubMed ID: 9698565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.